Authors: BRIASOULIS E JUDSON I PAVLIDIS N BEALE P GROOT Y VEERMAN G SCHUESSLER M RAMMOU D WALKER R HANAUSKE A

Citation: E. Briasoulis et al., PHASE-I TRIAL AND PHARMACOKINETICS OF BETA-D-GLUCOSYLISOPHOSPHORAMIDEMUSTARD (D-19575) ADMINISTERED AS A 6-HOUR INFUSION EVERY 3 WEEKS - AN EORTC-ECSG STUDY, Annals of oncology, 9, 1998, pp. 616-616

Authors: BRIASOULIS E JUDSON I PAVLIDIS N BEALE P WANDERS J GROOT Y VEERMAN G LOCHER M SCHUESSLER M TZAMAKOU E RAMMOU D WOLF L WALKER R HANAUSKE A

Citation: E. Briasoulis et al., A PHASE-I TRIAL OF D19575, A BETA-D-GLUCOSE-LINKED ISOPHOSPHORAMIDE MUSTARD GIVEN AS A 6-HOUR INFUSION, Annals of oncology, 9, 1998, pp. 473-473

Authors: VANTELLINGEN O PUNT CJA AWADA A WAGENER DJT PICCART MJ GROOT Y SCHAAF LJ HENRAR REC NOOIJEN WJ BEIJNEN JH

Citation: O. Vantellingen et al., A CLINICAL PHARMACOKINETICS STUDY OF CARZELESIN GIVEN BY SHORT-TERM INTRAVENOUS-INFUSION IN A PHASE-I STUDY, Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 377-384

Authors: HERBEN VMM HUININK WWT DUBBELMAN AC MANDJES IAM GROOT Y VANZOMEREN DMV BEIJNEN JH

Citation: Vmm. Herben et al., PHASE-I AND PHARMACOLOGICAL STUDY OF SEQUENTIAL INTRAVENOUS TOPOTECANAND ORAL ETOPOSIDE, British Journal of Cancer, 76(11), 1997, pp. 1500-1508

Authors: WOLFF I BENCH K BEIJNEN JH BRUNTSCH U CAVALLI F DEJONG J GROOT Y VANTELLINGEN O WANDERS J SESSA C

Citation: I. Wolff et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF CARZELESIN (U-80244) GIVEN DAILY FOR 5 CONSECUTIVE DAYS, Clinical cancer research, 2(10), 1996, pp. 1717-1723

Authors: MCLEOD HL GRAHAM MA AAMDAL S SETANOIANS A GROOT Y LUND B

Citation: Hl. Mcleod et al., PHASE-I PHARMACOKINETICS AND LIMITED SAMPLING STRATEGIES FOR THE BIOREDUCTIVE ALKYLATING DRUG E09, European journal of cancer, 32A(9), 1996, pp. 1518-1522